ALHC
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. insider trading
Alignment Healthcare, Inc. files with the SEC as a Hospital & Medical Service Plans company headquartered in Orange, CA. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent ALHC insider transactions
5 insiders traded ALHC on the open market between Apr 13, 2026 and Sep 17, 2026 — 1 purchase worth $197.6K, 23 sales worth $40.5M, of which 21 were pre-scheduled under a 10b5-1 plan.
- Bought
- $197.6K
- Sold
- $40.5M
- Net
- −$40.3M
- Insiders
- 5
21 of 23 on a 10b5-1 plan
Konowiecki Joseph S
EVP, Corporate Affairs · Director
−$202.4K
Sep 17, 2026
23,511 sh · $8.61
Kao John E10b5-1
Chief Executive Officer · Director
−$356.2K
Sep 14, 2026
27,400 sh · $13.00
Maroney Dawn Christine
President
−$1.6M
Sep 11, 2026
122,707 sh · $12.68
Kao John E10b5-1
Chief Executive Officer · Director
−$4.9M
Sep 11, 2026
385,270 sh · $12.68
Kao John E10b5-1
Chief Executive Officer · Director
−$2.2M
Sep 10, 2026
172,600 sh · $12.96
Maroney Dawn Christine10b5-1
President
−$70K
Aug 14, 2026
5,000 sh · $14.00
Kao John E10b5-1
Chief Executive Officer · Director
−$4.1M
Aug 10, 2026
298,000 sh · $13.88
Maroney Dawn Christine10b5-1
President
−$3.7M
Jul 15, 2026
177,068 sh · $20.83
Kao John E10b5-1
Chief Executive Officer · Director
−$5.5M
Jul 10, 2026
279,644 sh · $19.81
Kao John E10b5-1
Chief Executive Officer · Director
−$379K
Jul 10, 2026
18,356 sh · $20.65
Konowiecki Joseph S10b5-1
EVP, Corporate Affairs · Director
−$600K
Jul 01, 2026
25,000 sh · $24.00
Konowiecki Joseph S10b5-1
EVP, Corporate Affairs · Director
−$575K
Jun 26, 2026
25,000 sh · $23.00
Konowiecki Joseph S10b5-1
EVP, Corporate Affairs · Director
−$550K
Jun 18, 2026
25,000 sh · $22.00
Maroney Dawn Christine10b5-1
President
−$586.4K
Jun 15, 2026
30,000 sh · $19.55
Kim Hyong10b5-1
Chief Medical Officer
−$713.9K
Jun 12, 2026
35,951 sh · $19.86
Konowiecki Joseph S10b5-1
EVP, Corporate Affairs · Director
−$525K
Jun 11, 2026
25,000 sh · $21.00
Kao John E10b5-1
Chief Executive Officer · Director
−$1.5M
Jun 10, 2026
74,936 sh · $19.65
Kao John E10b5-1
Chief Executive Officer · Director
−$4.6M
Jun 10, 2026
223,064 sh · $20.60
Kent Mark D.
President - MSO
+$197.6K
Jun 02, 2026
14,848 sh · $13.31
Maroney Dawn Christine10b5-1
President
−$482.6K
May 15, 2026
30,000 sh · $16.09
Kao John E10b5-1
Chief Executive Officer · Director
−$4.7M
May 11, 2026
280,893 sh · $16.85
Kao John E10b5-1
Chief Executive Officer · Director
−$300K
May 11, 2026
17,107 sh · $17.54
Maroney Dawn Christine10b5-1
President
−$626.2K
Apr 15, 2026
30,000 sh · $20.87
Kao John E10b5-1
Chief Executive Officer · Director
−$1.7M
Apr 13, 2026
82,299 sh · $20.80
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Konowiecki Joseph SEVP, Corporate Affairs · Director | 23,511 | $8.61 | −$202.4K |
| Sep 14, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 27,400 | $13.00 | −$356.2K |
| Sep 11, 2026 | Maroney Dawn ChristinePresident | 122,707 | $12.68 | −$1.6M |
| Sep 11, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 385,270 | $12.68 | −$4.9M |
| Sep 10, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 172,600 | $12.96 | −$2.2M |
| Aug 14, 2026 | Maroney Dawn Christine10b5-1President | 5,000 | $14.00 | −$70K |
| Aug 10, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 298,000 | $13.88 | −$4.1M |
| Jul 15, 2026 | Maroney Dawn Christine10b5-1President | 177,068 | $20.83 | −$3.7M |
| Jul 10, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 279,644 | $19.81 | −$5.5M |
| Jul 10, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 18,356 | $20.65 | −$379K |
| Jul 01, 2026 | Konowiecki Joseph S10b5-1EVP, Corporate Affairs · Director | 25,000 | $24.00 | −$600K |
| Jun 26, 2026 | Konowiecki Joseph S10b5-1EVP, Corporate Affairs · Director | 25,000 | $23.00 | −$575K |
| Jun 18, 2026 | Konowiecki Joseph S10b5-1EVP, Corporate Affairs · Director | 25,000 | $22.00 | −$550K |
| Jun 15, 2026 | Maroney Dawn Christine10b5-1President | 30,000 | $19.55 | −$586.4K |
| Jun 12, 2026 | Kim Hyong10b5-1Chief Medical Officer | 35,951 | $19.86 | −$713.9K |
| Jun 11, 2026 | Konowiecki Joseph S10b5-1EVP, Corporate Affairs · Director | 25,000 | $21.00 | −$525K |
| Jun 10, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 74,936 | $19.65 | −$1.5M |
| Jun 10, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 223,064 | $20.60 | −$4.6M |
| Jun 02, 2026 | Kent Mark D.President - MSO | 14,848 | $13.31 | +$197.6K |
| May 15, 2026 | Maroney Dawn Christine10b5-1President | 30,000 | $16.09 | −$482.6K |
| May 11, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 280,893 | $16.85 | −$4.7M |
| May 11, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 17,107 | $17.54 | −$300K |
| Apr 15, 2026 | Maroney Dawn Christine10b5-1President | 30,000 | $20.87 | −$626.2K |
| Apr 13, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 82,299 | $20.80 | −$1.7M |
SEC Form 4 data, Q3 2024 to Q2 2026
ALHC insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 14 insiders traded ALHC on the open market: 1 purchase worth $197.6K and 234 sales worth $958.5M, 152 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 1 purchase ($197.6K) and 94 sales ($632.5M), by 11 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$197.6K1 buy | −$27.1M18 sales · 17 on a plan | |
| Q1 2026 | — | −$28M29 sales · 16 on a plan | |
| Q4 2025 | — | −$240.2M23 sales · 10 on a plan | |
| Q3 2025 | — | −$337.2M24 sales · 17 on a plan | |
| Q2 2025 | — | −$273.4M14 sales · 13 on a plan | |
| Q1 2025 | — | −$36.2M64 sales · 22 on a plan | |
| Q4 2024 | — | −$8.3M22 sales · 18 on a plan | |
| Q3 2024 | — | −$8.1M40 sales · 39 on a plan |
- Largest purchase
- +$197.6K of ALHC by Kent Mark D. (President - MSO) on Jun 02, 2026.
- Largest sale
- −$259.8M of ALHC by General Atlantic (ALN HLTH), L.P. (Director · 10% Owner) on May 19, 2025.
Open-market transactions through Jun 30, 2026most recent first
Maroney Dawn Christine10b5-1
President
−$586.5K
Jun 15, 2026
30,000 sh · $19.55
Kim Hyong10b5-1
Chief Medical Officer
−$714K
Jun 12, 2026
35,951 sh · $19.86
Kao John E10b5-1
Chief Executive Officer · Director
−$4.6M
Jun 10, 2026
223,064 sh · $20.60
Kao John E10b5-1
Chief Executive Officer · Director
−$1.5M
Jun 10, 2026
74,936 sh · $19.65
Maroney Dawn Christine10b5-1
President
−$482.7K
May 15, 2026
30,000 sh · $16.09
Kao John E10b5-1
Chief Executive Officer · Director
−$4.7M
May 11, 2026
280,893 sh · $16.85
Kao John E10b5-1
Chief Executive Officer · Director
−$300.1K
May 11, 2026
17,107 sh · $17.54
Maroney Dawn Christine10b5-1
President
−$626.1K
Apr 15, 2026
30,000 sh · $20.87
Kao John E10b5-1
Chief Executive Officer · Director
−$1.7M
Apr 13, 2026
82,299 sh · $20.80
Kao John E10b5-1
Chief Executive Officer · Director
−$4.2M
Apr 10, 2026
201,900 sh · $20.58
Kao John E10b5-1
Chief Executive Officer · Director
−$295.1K
Apr 10, 2026
13,801 sh · $21.38
Kao John E10b5-1
Chief Executive Officer · Director
−$2.7M
Apr 07, 2026
132,241 sh · $20.67
Kao John E10b5-1
Chief Executive Officer · Director
−$2.5M
Apr 07, 2026
117,759 sh · $21.40
Head James M
Chief Financial Officer
−$234K
Apr 07, 2026
11,100 sh · $21.08
Joyce Christopher J10b5-1
Chief Legal and Admin. Officer
−$320.5K
Apr 01, 2026
18,013 sh · $17.79
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Maroney Dawn Christine10b5-1President | 30,000 | $19.55 | −$586.5K |
| Jun 12, 2026 | Kim Hyong10b5-1Chief Medical Officer | 35,951 | $19.86 | −$714K |
| Jun 10, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 223,064 | $20.60 | −$4.6M |
| Jun 10, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 74,936 | $19.65 | −$1.5M |
| May 15, 2026 | Maroney Dawn Christine10b5-1President | 30,000 | $16.09 | −$482.7K |
| May 11, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 280,893 | $16.85 | −$4.7M |
| May 11, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 17,107 | $17.54 | −$300.1K |
| Apr 15, 2026 | Maroney Dawn Christine10b5-1President | 30,000 | $20.87 | −$626.1K |
| Apr 13, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 82,299 | $20.80 | −$1.7M |
| Apr 10, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 201,900 | $20.58 | −$4.2M |
| Apr 10, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 13,801 | $21.38 | −$295.1K |
| Apr 07, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 132,241 | $20.67 | −$2.7M |
| Apr 07, 2026 | Kao John E10b5-1Chief Executive Officer · Director | 117,759 | $21.40 | −$2.5M |
| Apr 07, 2026 | Head James MChief Financial Officer | 11,100 | $21.08 | −$234K |
| Apr 01, 2026 | Joyce Christopher J10b5-1Chief Legal and Admin. Officer | 18,013 | $17.79 | −$320.5K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Alignment Healthcare, Inc. company record
- SEC industry classification
- Hospital & Medical Service Plans
- Headquarters
- Orange, CA
- Incorporated in
- DE
- Listed on
- Nasdaq
- SEC Central Index Key
- 0001832466
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.
After insiders bought ALHC
What the stock actually did in the 90 days following each open-market purchase
Don't check ALHC — let it ping you
Get told the moment an insider moves on ALHC
Pro watches Alignment Healthcare, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add ALHC to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read ALHC insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- Are ALHC insiders buying or selling?
- Between Apr 13, 2026 and Sep 17, 2026, 5 Alignment Healthcare, Inc. insiders made 1 open-market purchase worth $197.6K and 23 sales worth $40.5M, a net sale of $40.3M. 21 of the sales were pre-scheduled under a Rule 10b5-1 plan.
- How much ALHC stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 14 Alignment Healthcare, Inc. insiders made 1 open-market purchase worth $197.6K and 234 sales worth $958.5M. 152 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 1 purchase ($197.6K) and 94 sales ($632.5M). The largest purchase was Kent Mark D. buying $197.6K on Jun 02, 2026. The largest sale was General Atlantic (ALN HLTH), L.P. selling $259.8M on May 19, 2025.
- What was the largest recent ALHC insider trade?
- Kao John E (Chief Executive Officer · Director) sold $5.5M of ALHC stock on Jul 10, 2026 at about $19.81 a share, under a pre-scheduled 10b5-1 plan.
- When did an insider last buy ALHC shares?
- The most recent open-market purchase on file is Kent Mark D. (President - MSO) buying $197.6K on Jun 02, 2026.
- Where does ALHC insider trading data come from?
- From the Form 4 filings Alignment Healthcare, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.